0001209191-23-036066.txt : 20230609 0001209191-23-036066.hdr.sgml : 20230609 20230609193952 ACCESSION NUMBER: 0001209191-23-036066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wettig Thane CENTRAL INDEX KEY: 0001815638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231006798 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-07 0 0000921299 FIBROGEN INC FGEN 0001815638 Wettig Thane C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-06-07 4 S 0 472 17.0356 D 112681 D Common Stock 2023-06-07 4 S 0 1286 17.0377 D 111395 D Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-06-09